Carbohydrate Antigen 125-guided Therapy in Heart Failure

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Preliminary data suggest a potential role for monitoring and up-titrate pharmacological therapy of plasma levels of antigen carbohydrate 125 (CA125) following and admission for acute heart failure (AHF). This study will evaluate the effect of a CA125-guided management strategy versus standard therapy on the composite endpoint of 1-year all-cause mortality or readmission for AHF in patients recently discharged for AHF.
Epistemonikos ID: d7c30ce81ee31dfb9dc746c58dc0ed362c098e70
First added on: May 11, 2024